Ground Ivy (Glechoma hederacea)

Ground ivy (Glechoma hederacea) is a European perennial herb containing rosmarinic acid, flavonoids such as luteolin and apigenin, and volatile terpenoids including pinocamphone and pulegone. These phytochemicals contribute to its traditional use as an anti-inflammatory and expectorant remedy, though rigorous clinical trials confirming efficacy in humans remain absent.

Origin & History

Ground ivy is a perennial herb native to Europe and western Asia, belonging to the Lamiaceae family. The aerial parts, including leaves and stems, are harvested and processed into extracts or essential oils through solvent extraction or drying methods.

Historical & Cultural Context

Ground ivy has a documented history in European ethnobotany, primarily used as a flavoring and clearing agent in brewing beer before the adoption of hops. Its use in other traditional medicine systems is not detailed in the research.

Health Benefits

• Provides a source of phenolic acids and flavonoids, although clinical efficacy is not established (phytochemical composition studies). • Traditionally used as a flavoring and clearing agent in brewing beer, but clinical benefits are not documented (historical use). • Contains essential oils and terpenoids, yet their health effects lack clinical validation (phytochemical composition). • Rich in vitamins and minerals such as vitamin C and zinc, but no clinical outcomes reported (constituent analysis). • Known for its polyphenolic content, though no clinical trials confirm specific health benefits (phytochemical composition).

How It Works

Rosmarinic acid in ground ivy inhibits cyclooxygenase (COX-1 and COX-2) enzymes and suppresses NF-κB signaling, reducing prostaglandin E2 synthesis and inflammatory cytokine production. Luteolin and apigenin act as inhibitors of phosphodiesterase and modulators of MAPK pathways, potentially contributing to antispasmodic and mild bronchodilatory effects. The volatile monoterpene pinocamphone may exhibit mild antimicrobial activity by disrupting bacterial cell membrane integrity, though these mechanisms are largely characterized in in vitro and animal models rather than human trials.

Scientific Research

No specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses are cited in the research. The sources focus primarily on the phytochemical composition and traditional uses of ground ivy without providing clinical outcomes data.

Clinical Summary

No large-scale randomized controlled trials have been conducted specifically on Glechoma hederacea in human populations. In vitro studies demonstrate antioxidant activity of ground ivy extracts with IC50 values for DPPH radical scavenging reported in the range of 20–50 µg/mL, comparable to moderate-potency botanical antioxidants. Animal studies in rodents have suggested anti-inflammatory and hepatoprotective effects at doses of 100–400 mg/kg body weight, but these findings have not been translated into validated human clinical outcomes. The overall evidence base remains at a preclinical and ethnobotanical level, and no standardized therapeutic dose has been established for human use.

Nutritional Profile

Ground Ivy (Glechoma hederacea) is a low-calorie herb with limited macronutrient content, consumed primarily for its bioactive phytochemicals rather than macronutritional value. Moisture content is high (~85-90% in fresh leaves). Crude protein is approximately 2-3% dry weight, with minimal fat (<1% dry weight) and moderate fiber content (~15-20% dry weight as crude fiber). Key bioactive compounds include: Phenolic acids — rosmarinic acid (reported at ~1-3 mg/g dry weight), caffeic acid, and chlorogenic acid derivatives; Flavonoids — luteolin, apigenin, and hyperoside (quercetin-3-galactoside), with total flavonoid content estimated at 5-15 mg/g dry weight in aerial parts; Essential oils (~0.03-0.06% of fresh weight) dominated by pinocamphone, pulegone, menthone, limonene, and alpha-pinene, though composition varies significantly with geographic origin and harvest time; Terpenoids — ursolic acid and oleanolic acid (pentacyclic triterpenes) present in measurable quantities (~0.5-2 mg/g dry weight); Tannins contributing to astringency, estimated at 2-5% dry weight; Bitter iridoids including glechomanolide. Mineral content includes moderate potassium, calcium (~200-400 mg/100g dry weight estimated), and trace iron and zinc. Vitamin C is present in fresh material but degrades rapidly with drying or processing. Bioavailability note: Rosmarinic acid exhibits relatively good oral bioavailability compared to other phenolic acids; however, most phytochemical data derives from in vitro extraction studies, and in vivo bioavailability in humans is not well characterized for this specific species.

Preparation & Dosage

The research does not provide clinically studied dosage ranges or standardized extract concentrations for ground ivy in human studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rosemary, Thyme, Peppermint, Sage, Oregano

Safety & Interactions

Ground ivy contains the volatile ketone pulegone, which in high concentrations is hepatotoxic and nephrotoxic, as demonstrated in animal toxicity studies; use of concentrated essential oil extracts carries meaningful risk. The herb may potentiate anticoagulant drugs such as warfarin due to rosmarinic acid's platelet-aggregation-inhibiting properties, and concurrent use warrants caution. Ground ivy is contraindicated in pregnancy, as pulegone and other constituents may stimulate uterine contractions and carry potential abortifacient risk. Individuals with epilepsy should also avoid high doses, as some volatile terpenoids may lower seizure threshold.